New study aims to protect transgender community from HIV and substance harm

NCT ID NCT07512856

First seen Apr 16, 2026 · Last updated May 14, 2026 · Updated 5 times

Summary

This study is testing a special harm reduction service designed for transgender women, men, and non-binary people in Thailand who use substances or engage in chemsex. The goal is to increase use of HIV prevention pills (PrEP), reduce sexually transmitted infections, and improve mental health. About 140 participants will be followed for 12 months to see if the service helps them stay healthier and safer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBSTANCE USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tangerine Clinic, Institute of HIV Research and Innovation

    RECRUITING

    Pathum Wan, Bangkok, 10330, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.